Blogs
Immunoassays are bioanalytical methods that generally use antibodies to detect and quantify specific analytes, often proteins, in biological samples. The process involves the capture of a target protein by an immobilized antibody, followed by its detection with another antibody conjugated either to enzymes, such as phosphatase alkaline or horseradish peroxidase…
March 5
- March 9
The AD/PD™ 2024: Alzheimer’s & Parkinson’s Diseases Conference is set to take place in Lisbon, Portugal, from March 5th to 9th, 2024. This prestigious event, dubbed the “main event of the year in the field of neurodegenerative diseases,” promises to gather leading experts from around the world to share the…
May 13
- May 16
Mark your calendars, life science innovators! The AAPS National Biotechnology Conference (NBC) is gearing up for another groundbreaking year, and KCAS Bio is excited to be at the forefront of the action. From May 13th to 16th, 2024, San Francisco will transform into a hub of cutting-edge research, industry breakthroughs,…
February 29
- March 1
Biomarkers 2024 is a three-day event that will bring together leading experts from the field of biomarker research to discuss the latest trends and tools in this rapidly evolving field. The event will feature over 90 cutting-edge presentations, 8+ hours of valuable networking sessions, and an exhibition hall showcasing the…
Blogs
Immunogenicity refers to the ability of a substance, such as an antigen or a vaccine, to provoke an immune response in an organism. The recognition of the substance as foreign triggers an immune response, which involves the production of antibodies and the activation of immune cells to fight against or…
Webinars
Produced by AAPS Organized by Sciex Recorded on December 6, 2023 eChalkTalk available here. Webinar Description: In this webinar, scientists from KCAS Bio, along with specialists from SCIEX Biopharma & Pharma Solutions discuss • Developing robust assays for PD biomarkers and their challenges…
Blogs
Ligand binding assays (LBAs) have been our core activity for decades. LBAs are commonly used to measure interactions between two proteins, a ligand and its receptor, a monoclonal antibody (mAb) and its target, or biologics and Anti-Drug Antibodies (ADA). Throughout the development of New…
Blogs
A biomarker is a defined characteristic that is measured as an indicator of normal biological processes, pathogenic processes, or biological responses to an exposure or intervention, including therapeutic interventions(1). With the development of innovative and personalized therapies, biomarker tracking is increasingly important to support the clinical development…
Blogs
Biologics are drugs derived from complex molecules like antibodies. Over the last two decades they have re-emerged as…
Blogs
Understanding the interactions between drugs and biological systems is critical for the success of a new drug. One key tool in this process is functional assays. Functional assays are customized assays that evaluate the impact of drugs on the functionality of cells. They test for a drug’s specific biological mechanism…
Blogs
Cell and Gene Therapies (CGTs) has an estimated market size value in 2022 of USD 8.22 billion and a revenue forecast in 2030 of USD 24.5 billion. This is a CAGR (compound annual growth rate) of 14.6% from 2022 to 2030. Needless to say, the…
Blogs
Due to its ability to analyze multiple parameters across different cell types within a sample, flow cytometry provides rich and clinically valuable data sets from even small volumes of blood. However, flow cytometry is a challenging platform to master, and requires significant investment in equipment and technical training.